Cholestatic Liver Disease
Gastroenterology
1
Pipeline Programs
1
Companies
1
Clinical Trials
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
1
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
1 companies ranked by most advanced pipeline stage
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
Mirum PharmaceuticalsMaralixibat
Clinical Trials (1)
Total enrollment: 52 patients across 1 trials
MRX-800: A Long-Term Safety Study of Maralixibat in the Treatment of Cholestatic Liver Disease in Subjects Who Previously Participated in a Maralixibat Study
Start: Jan 2020Est. completion: Sep 202452 patients
Phase 2Completed
Related Jobs in Gastroenterology
Specialty Representative, Gastroenterology – Minneapolis, Minnesota
AbbVie
Remote
15h ago
Head of Drug Product Development
Ironwood Pharmaceuticals
Boston, Massachusetts, United States
16h ago
$246K - $287K/yr
Regulatory Affairs Associate
Ferring Pharmaceuticals
Istanbul, Turkey
Yesterday
Key Account Director, Diagnostics and Research
Tempus
Remote
Yesterday
$150K - $200K/yr
Senior Sterilization Validation Engineer (m/f/d)
Johnson & Johnson
Beerse, Antwerp, Belgium
Yesterday
Senior Financial Analyst - Supply Chain Finance & Transformation (m/f/d)
Johnson & Johnson
Norderstedt, Schleswig-Holstein, Germany
Yesterday
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
1 companies competing in this space